Work

Table S3 from Phosphoproteomics Reveals MAPK Inhibitors Enhance MET- and EGFR-Driven AKT Signaling in KRAS-Mutant Lung Cancer

Year: 2023

Type: other

Abstract: Table S3. Top 10 pathways enriched by GeneGO analysis of selumetinib-regulated phosphoproteins.

DOI: 10.1158/1541-7786.22514097.v1

Authors: Jae-Young Kim, Eric A. Welsh, Bin Fang, Yun Bai, Fumi Kinose, Steven A. Eschrich, John M. Koomen, Eric B. Haura

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362536593

Cites:

Cited by:

Related to: 10